SEC Form 4 · accession 0001209191-19-012814
MANNKIND CORP · MNKD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Kendall
Officer — Chief Medical Officer
Period of report
Feb 20, 2019
Accepted (ET)
Feb 25, 2019 · 6:05 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899460
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | Feb 20, 2019 | A | 37,026 | $0.00 | A | 44,850 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
- F2Restricted stock units shall vest and be delivered on February 20, 2020.